More recently, a French group reported increased tumor cell death in vitro and delayed tumor growth with prolonged lifespan in tumor-bearing mice after treatment with venetoclax, cetuximab (an EGFR inhibitor) and radiation. The gene discussed is EGFR; the disease is neoplasm.